Clinical Trials Browser

Phase 2 × Terminated × Seminoma × Clear all

NCT01593241 2025-02-13

Therapy De-escalation in Seminoma Stage IIA/B

Phase 2 Terminated

Seminoma

NCT00042952 2013-01-17

Imatinib Mesylate in Treating Patients With Progressive, Refractory, or Recurrent Stage II or Stage III Testicular or Ovarian Cancer

Phase 2 Terminated

Dysgerminoma, Testicular Neoplasms, Seminoma